Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report
- Author(s)
- Yun, JSW; Scardamaglia, L; Tan, CG; McCormack, CJ;
- Details
- Publication Year 2022-05,Volume 63,Issue #2,Page e155-e158
- Journal Title
- Australasian Journal of Dermatology
- Publication Type
- Case report
- Abstract
- Since the concurrence of bullous pemphigoid (BP) and psoriasis was first reported in 1929, an increasing number of studies has been published to analyse their relationship in recent years. However, the pathogenesis of the concurrence is not yet well understood, and the coexistence of the two conditions imposes a difficult therapeutic challenge. This case report demonstrates the first case of secukinumab achieving a dramatic clinical improvement of both chronic psoriasis and active BP.
- Keywords
- Antibodies, Monoclonal, Humanized/therapeutic use; *Graft vs Host Disease; Humans; *Pemphigoid, Bullous/complications/drug therapy/pathology; *Psoriasis/complications/drug therapy/pathology; bullous pemphigoid; immunobullous; interleukin-17; monoclonal antibody; psoriasis
- Department(s)
- Surgical Oncology
- PubMed ID
- 35138643
- Publisher's Version
- https://doi.org/10.1111/ajd.13803
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-05-16 05:12:13
Last Modified: 2025-05-16 05:13:40